Perspective Therapeutics, Inc.

Historical 13F Holders

Symbol
CATX
CUSIP
46489V302
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 46489V302 since 12/18/2024, largest first.

Filer % of Class Filed
Commodore Capital LP 13G
9.9% 2/9/2026
Event 2/2/2026
Lantheus Holdings, Inc. 13D/A
7.7% 9/23/2026
Event 9/21/2026
TCG Crossover GP II, LLC 13G
6.9% 2/6/2026
Event 2/3/2026
BlackRock, Inc. 13G 6.8% 7/29/2026
Event 6/30/2026
Qatar Investment Authority 13G 6.2% 2/5/2026
Event 2/4/2026
Millennium Management LLC 13G/A
5.5% 8/13/2026
Event 8/7/2026
State Street Corp 13G 5.3% 8/7/2026
Event 6/30/2026
Avidity Partners Management LP 13G
5.3% 3/10/2026
Event 2/20/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Morgan Stanley 13G/A 2.6% 5/12/2026
Event 3/31/2026
FMR LLC 13G/A
0.4% 12/5/2025
Event 11/28/2025
Janus Henderson Group PLC 13G/A 0% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 3 106 k $291 k
2026 Q2 133 89.3 M $306 M
2026 Q1 144 84.6 M $351 M
2025 Q4 119 36.4 M $102 M
2025 Q3 106 43.0 M $147 M
2025 Q2 100 42.2 M $145 M
2025 Q1 114 44.1 M $94.0 M
2024 Q4 141 47.1 M $150 M
2024 Q3 132 49.1 M $654 M
2024 Q2 106 38.7 M $386 M